Lv6
1960 积分 2023-12-25 加入
Efficacy of mepolizumab in patients with COPD & type 2 inflammation: Pooled Phase III trial results
9个月前
已关闭
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
9个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
9个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
9个月前
已完结
Responders to biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric observational real-life study
9个月前
已完结
皖公网安备34019202002308
